View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
STUDY - GAIN 2 - dtEC-dtD, Epirubicin 38-120 / Cyclophosphamide 450-1200, Breast Cancer, Part A
Protocol-ID: 558 V1.0 (Mini), STUDY-GAIN-2-dtEC-dtD, EPIR(38-120)/CYCL(450-1200), Breast Ca, AStudy protocol, available to authorized participants only.
Indication(s)
- Breast Cancer; ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.09.2017